Introduction
============

γ-Amino butyric acid (GABA),[^6^](#FN5){ref-type="fn"} the main inhibitory neurotransmitter in the mammalian brain, acts at two main classes of receptors, the ionotropic GABA~A~ and metabotropic GABA~B~ receptors. GABA~A~ receptors are fast ligand gated Cl^−^ channels. The GABA~B~ receptor (GABA~B~R) is a heteromeric G-protein-coupled receptor comprising GABA~B1~ and GABA~B2~ subunits that exert much longer lasting synaptic inhibition ([@B1]). The GABA~B1~ subunit contains the ligand-binding domain ([@B2]), and GABA~B2~ couples to the G-protein to down-regulate adenylate cyclase ([@B3]). GABA~B~Rs are present at both post- and presynaptic compartments and changes in their number, activity, and/or localization can dramatically alter the level of synaptic inhibition by activating inwardly rectifying K^+^ channels and inhibiting Ca^2+^ channels (for review, see Refs. [@B4][@B5][@B7]).

The surface expression of most types of G-protein-coupled receptors is down-regulated by agonist-evoked recruitment of G protein-coupled receptor-dependent kinases, β-arrestin binding, endocytosis, and subsequent degradation or recycling ([@B8]). However, GABA~B~Rs are atypical. Neither native nor recombinant GABA~B~Rs are G protein-coupled receptor-dependent kinase substrates, and they do not undergo agonist-induced internalization ([@B9], [@B10]). They do, however, display constitutive endocytosis ([@B11]), and it has been proposed that they undergo both very rapid endocytic recycling ([@B12], [@B13]) and membrane lateral diffusion ([@B14]).

GABA~B~Rs are abundant at glutamatergic synapses ([@B15], [@B16]) where they engage in reciprocal cross-talk with NMDARs ([@B17][@B18][@B20]). Sustained glutamate application promotes GABA~B~R endocytosis, sorting to lysosomal degradation and consequent decreased surface expression ([@B10], [@B21]). Prolonged activation of NMDARs results in CaMKII-mediated phosphorylation of GABA~B1~ causing a dynamin- and CaMKII-dependent endocytosis of GABA~B~Rs ([@B22]). Additionally, AMP kinase phosphorylation and subsequent protein phosphatase 2A dephosphorylation of GABA~B2~ promotes lysosomal degradation of the endocytosed receptors ([@B23]). These studies demonstrate that pharmacological manipulation of NMDARs can influence GABA~B~R surface expression and endosomal trafficking. However, they rely on the sustained bath application of relatively high doses of agonist that will activate all functional NMDARs. This is an important consideration because it is well established that NMDAR activation can be either beneficial or cytotoxic, depending on the location and intensity of stimulation. Activation of synaptic NMDARs is a trigger for synaptic plasticity and can be neuroprotective via nuclear Ca^2+^ signaling, whereas prolonged activation of extrasynaptic NMDARs promotes cell death ([@B24]).

Differences in the effects of synaptic and extrasynaptic NMDARs on GABA~B~R trafficking have not been reported. In this study, we tested the hypothesis that different types of NMDAR activation have different affects on GABA~B~R expression and trafficking. We show that selective activation of synaptic receptors using a NMDA receptor-dependent chemically induced LTP protocol (chemLTP) ([@B25], [@B26]) enhances both GABA~B1~ and GABA~B2~ surface expression via increased recycling. In contrast, oxygen/glucose deprivation (OGD), which among other effects, elicits excessive glutamate release and excitotoxic activation of NMDARs ([@B24]) and increases GABA~B1~ but decreases GABA~B2~ surface expression. These findings demonstrate that the surface expression of GABA~B~Rs is differentially regulated in response to synaptic (physiological) and global (pathophysiological) stimulation of NMDARs.

EXPERIMENTAL PROCEDURES
=======================

### 

#### Antibodies and Chemicals

Primary antibodies used were as follows: rabbit anti-GABA~B1a,b~ (Santa Cruz Biotechnology, for Western blotting), guinea pig anti-GABA~B1a,b~ (for all imaging) and anti-GABA~B2~ (Chemicon, Intl., Temecula, CA), and mouse monoclonal anti-β-actin (Sigma-Aldrich). HRP-conjugated secondary antibodies used were goat anti-rabbit IgG, goat anti-mouse IgG, goat anti-rabbit IgG, and goat anti-guinea pig IgG (Sigma-Aldrich). Fluorochrome-conjugated secondary antibodies used were goat anti-rabbit Alexa Fluor 488 (green), goat anti-guinea pig Alexa Fluor 568 (red), and goat anti-mouse Alexa Fluor 568 (red) (Molecular Probes, Eugene, OR). The anti-HA tag (6E2) mouse monoclonal antibody is an Alexa Fluor® 488 conjugate (Cell Signaling).

#### Expression Constructs, Transfection, and Transduction

Cultured hippocampal cells were transfected using Lipofectamine 2000 (Invitrogen). GABA~B~R expression constructs pmyc-GABA~B1a~ and pHA-GABA~B2~ were kind gifts from Steve Moss and Benny Bettler, respectively. Cells were imaged 48 h after transfection. RFP-Rab4 constructs in pSinRep5 and pcDNA vectors were gifts from Jose Esteban. Hippocampal cells were transduced 16 h prior to treatment. For some experiments the RFP tag was changed to a GFP for Rab4 and Rab11. We also made Sindbis containing fluorophore-tagged wild-type and mutant CB1 receptors, which were used as infection and neuronal viability controls for GABA~B~ expression in neurons.

#### Primary Hippocampal/Cortical Neuronal Cultures

Primary hippocampal and cortical neuronal cultures were prepared from embryonic day 18 rats exactly as described previously ([@B27]).

#### LTP Protocol

Cultured cortical neurons were washed with LTP buffer (150 m[m]{.smallcaps} NaCl, 2 m[m]{.smallcaps} CaCl~2~, 5 m[m]{.smallcaps} KCl, 10 m[m]{.smallcaps} HEPES, 30 m[m]{.smallcaps} glucose, 0.5 μ[m]{.smallcaps} tetradotoxin, 1 μ[m]{.smallcaps} strychnine, 20 μ[m]{.smallcaps} bicuculline; pH 7.4) as described previously ([@B25], [@B26]). For the controls, 50 μ[m]{.smallcaps} AP5 was added 5 min before adding 200 μ[m]{.smallcaps} glycine. To induce LTP, glycine was added to the cells for 3 min at 37 °C and then replaced with LTP buffer for the times indicated (5, 10, or 20 min).

#### OGD Protocol

On days *in vitro* 14 to 21, the cultures were subjected to OGD exactly as described previously ([@B28]). Briefly, neurons were washed twice with OGD medium (1.26 m[m]{.smallcaps} CaCl~2~, 5.36 m[m]{.smallcaps} KCl, 136.89 m[m]{.smallcaps} NaCl, 0.44 m[m]{.smallcaps} KH~2~PO~4~, 0.34 m[m]{.smallcaps} Na~2~HPO~4~, 0.49 m[m]{.smallcaps} MgCl~2~, 0.44 m[m]{.smallcaps} MgSO~4~, 25 m[m]{.smallcaps} HEPES, 4 m[m]{.smallcaps} NaHCO~3~, 1% penicillin/streptomycin; pH 7.2). The medium was then exchanged for OGD medium previously bubbled with N~2~/CO~2~ (95%/5%) for 10 min. The cultures were then transferred to an anaerobic chamber at 37 °C with N~2~-enriched atmosphere, where they were maintained for 30, 45, or 60 min. After OGD, the cells were removed from the chamber, washed twice with PBS, and processed either for biotinylation or imaging. Where appropriate, drugs were incorporated in culture medium and in OGD medium during the indicated periods.

#### Cell-surface Biotinylation

Neurons were biotinylated using the membrane impermeable and cleavable biotinylation reagent sulfosuccinimidyl-2-(biotinamido) ethyl-1,3-dithiopropionate (EZ-Link Sulfo-NHS-SS-biotin) (0.15 mg/ml in PBS, Pierce) for 10 min at 4 °C as described previously ([@B29]). The intracellular protein β-actin was used as a control. Bands were quantified using NIH ImageJ software (version 1.30) and normalized to the total receptor fraction. Unpaired Student\'s *t* tests were performed with a Newman-Keuls post-test for multiple comparison data sets.

#### Endocytosis/Recycling Experiments

GABA~B~R endocytosis and recycling was measured by the decrease of internalized GABA~B~Rs labeled with cleavable (S = S linked) biotin. Cortical cultures were surface biotinylated as described above, and cells were transferred to 37 °C for 30 min to allow endocytosis to occur. Cells were then activated by chemLTP protocol and incubated for the times indicated to allow internalized receptors to recycle back to the surface. The cells were then cooled to 4 °C and incubated with glutathione cleavage buffer (twice for 15 min each at 4 °C) to ensure complete cleavage of surface biotin. Cells were then washed twice with 10 m[m]{.smallcaps} iodoacetamide-PBS solution to quench excess glutathione. Residual biotinylated (internalized) receptors were then isolated by streptavidin pull down, and GABA~B~R subunits were detected by Western blotting. The rate of disappearance of biotinylated GABA~B~Rs provides a measure of receptor recycling. Leupeptin was included throughout to block protein degradation.

#### Live Cell Imaging Experiments

Imaging was perfomed using a Zeiss LSM 510 confocal microscope. Dissociated hippocampal neurons were transfected with p*HA*-GABA~B2~ expression vector and used 48 h later. At the beginning of the experiment, HA-reactive sites on the cell surface of neurons expressing HA-GABA~B2~ were labeled with an excess of anti-HA coupled to Alexa Fluor 488 (1:200) at the same time as the glycine/vehicle application (LTP protocol described above). Neurons were quickly washed twice in LTP buffer, and the fluorescence at time zero was acquired. Cells were kept a further 10 min in LTP buffer without glycine and incubated again with HA-Alexa Fluor 488 to label the newly surface inserted HA-GABA~B2~. Neurons were quickly washed twice, and the fluorescence at 10 min was acquired. The same process was repeated for 20 min. Green fluorescence at 0, 10, and 20 min were recorded in the same cell as a series of Z stacks (0.25-μm spacing between single confocal slices). The rate of receptors recycled or exocytosed in an individual cell was then determined from the zero control (*t* = 0) conditions in the same cell as an increase in the fluorescence after 10 and 20 min. Differences in expression were normalized to the mean of the fluorescence at time zero. Statistical analysis of differences between experimental groups was performed using one-way analysis of variance followed by post hoc Tukey\'s test calculated using SigmaStat software.

#### Transferrin Recycling Assay

Neurons were incubated with Alexa Fluor 488 Transferrin (10 μg/ml) in serum-free Neurobasal media for 30 min at 37 °C to reach equilibrium. Cells were then washed with PBS twice, and LTP or OGD protocols were performed as described above. After the indicated times, cells were washed twice and processed for immunostaining. Cells transduced with Rab viruses were incubated for 12 to 14 h to allow Rab protein expression before they were used for the recycling experiments. Briefly, neurons were fixed with 2% paraformaldehyde, 4% sucrose in PBS for 20 min and then blocked in 2% serum, 0.02% digitonin for 60 min at room temperature. Cells were then successively incubated with anti GABA~B1~ or GABA~B2~ antibodies overnight at 4 °C and with Cy3-conjugated secondary antibodies for 30 min at room temperature. Confocal fluorescence images from the Alexa Fluor 488, and Cy3 channels were recorded as a series of Z stacks using a Zeiss LSM 510 confocal laser-scanning station with an oil immersion 63 × 1.4 numerical aperture objective (Zeiss). Three-dimensional volumes of z stacks (0.25 μm spacing between single confocal slices) were analyzed using image processing and analysis in Java (ImageJ). The degree of co-localization was assessed in whole cell volumes and sub-volumes by calculating the Pearson\'s correlation coefficient in the region of interest using a semi-automated algorithm embedded in the JaCoP plugin of ImageJ software ([@B31]). The co-localization plugin also performed a two-step analysis to calculate the Pearson\'s correlation coefficient for the original data and for a large set (∼1000) of images randomized with a grain size determined by the point spread function of the microscope objective. If the Pearson\'s correlation coefficient of the original image was not greater than 95% of the randomized images, then the co-localization analysis did not continue. In addition, user bias in setting analysis parameters was avoided by using an automated thresholding procedure ([@B31]). Histograms presenting the mean correlation coefficient (derived from 19 to 31 cells assessed per treatment condition) are shown with S.D. bars in all figures. Tests of statistical significance for differences between pairwise combinations were calculated using the two-tailed Student\'s *t* test.

#### Immunoblotting

Proteins were blotted onto Immobilon-P membrane (Millipore) and probed with appropriate primary antibodies overnight after blocking with 5% low-fat milk in TBST ([@B32]). For detection, the membrane was incubated with HRP-conjugated secondary antibodies (Sigma, 1:10,000 dilution) for 60 min followed by substrate incubation with BM chemiluminescence blotting substrate (POD) (Roche Applied Science) or SuperSignal West Femto (Pierce). The chemiluminescence signal was detected on Hyperfilm HP (Amersham Biosciences).

RESULTS
=======

### 

#### Surface Expression of GABA~B1~ and GABA~B2~ Subunits

The steady-state expression of endogenous GABA~B1~/GABA~B2~ subunits in cultured cortical neurones (15--20 days *in vitro*) was determined by surface biotinylation. Under resting conditions 24.59% ± 2.45 of GABA~B1~ and 49.6% ± 1.19 of GABA~B2~ is surface-expressed ([Fig. 1](#F1){ref-type="fig"}, *A* and *B*). The anti-GABA~B1~ antibody recognizes both GABA~B1a~ and GABA~B1b~ subunit isoforms, and both are included in the quantification. Consistent with previous reports ([@B19], [@B33]), these results indicate that there is a larger pool of intracellular GABA~B1~ than GABA~B2~ and infer that the two subunits are regulated by distinct trafficking pathways.

![**Bath application of NMDA decreases surface GABA~B~Rs.** *A*, GABA~B1~ and GABA~B2~ surface expression was assessed by surface biotinylation. The total and cell surface GABA~B~ was determined as described under "Experimental Procedures." *Lane numbers* refer to the amount/percentage of protein loaded compared with 100% of the total protein: GABA~B1~ L1, 4.1%; L2, 8.3%; L3, 16.6%; L4, 33.3%; L5, 50%; and L6, 100%; GABA~B2~ L1, 15%; L2, 25%; L3, 50%; L4, 75%; L5, 50%; and L6, 100%. Blots were probed with anti- GABA~B~ antibodies and reprobed with anti-β-actin antibody to ensure equal loading and the specificity of surface biotinylation. Anti- GABA~B1~ antibody from Santa Cruz Biotechnology was used for blotting, and both the GABA~B1a~ and GABA~B1b~ isoforms were included in the analysis. *B*, quantification of GABA~B1~ and GABA~B2~ protein surface expression ratio (surface to total) measured by biotinylation assays illustrated in *A*. The results shown are the ratios of three independent experiments (*n* = 3). *C*, effect of NMDA on GABA~B1~/GABA~B2~ complex surface expression assessed by surface biotinylation. Cortical neurons were treated with 50 μm NMDA or 50 μm NMDA + 50 μm AP5 for 5 min and then incubated for the times indicated without any drugs. *D*, quantification of the effects of NMDA on GABA~B1~ and GABA~B2~ protein surface expression ratio (surface to total) measured by biotinylation assays illustrated in *C*. The results shown are the ratios of three independent experiments (*n* = 3). \*\*\*, *p* ≤ 0.005 compared with control (Students\'s *t* test). *E*, effects of the proteasome inhibitor MG132 and the lysosome inhibitor leupeptin (*LeuP*) on NMDA-mediated GABA~B1~/GABA~B2~ surface expression. Cultured cortical neurons were treated as in *C* with addition of either 10 μ[m]{.smallcaps} MG132 or 10 μ[m]{.smallcaps} leupeptin and incubated for 90 min. *F*, quantification of the effects of MG132 and leupeptin inhibitors on GABA~B1~ and GABA~B2~ protein surface expression ratio (surface to total) measured by biotinylation assays as illustrated in *E*. The results shown are the ratios of four independent experiments (*n* = 4). \*\*, *p* ≤ 0.01; \*\*\*, *p* ≤ 0.005 compared with control (*Ctrl*; Student\'s *t* test).](zbc0131477440001){#F1}

#### Global Activation of Extrasynaptic NMDARs Causes GABA~B~R Internalization

Bath application of glutamate ([@B10], [@B21]) or NMDA ([@B22], [@B23]) has been reported to decrease GABA~B~R surface expression. We recapitulated those results by treating neurons with 50 μ[m]{.smallcaps} NMDA ± 50 μ[m]{.smallcaps} AP5 (NMDAR antagonist) for 5 min, allowing the neurons to recover for 30, 60, or 90 min and then measuring surface GABA~B1~ and GABA~B2~. The amount of surface expressed GABA~B1~ and GABA~B2~ was decreased after 30 min and by 90 min after NMDAR activation, and surface GABA~B1~ and GABA~B2~ were levels were decreased by 79.3% ± 4 and 86.8% ± 3.3, respectively ([Fig. 1](#F1){ref-type="fig"}, *C* and *D*). Furthermore, we demonstrate that both the proteasome inhibitor MG132 and the protease inhibitor leupeptin effectively inhibit NMDAR-induced GABA~B~R loss. These data indicate that NMDAR activation causes GABA~B~R degradation ([Fig. 1](#F1){ref-type="fig"}, *E* and *F*) and confirm that the stimulation protocols and trafficking event observed in our cultures are directly comparable with previous reports using glutamate as the agonist ([@B10], [@B21]).

#### Selective Activation of Synaptic NMDARs Promotes GABA~B~R Surface Expression

Synaptic and extrasynaptic NMDARs play different roles in neuronal signaling. Activation of synaptic NMDARs mediates synaptic plasticity, whereas activation of extrasynaptic NMDARs leads to excitoxicity ([@B34]). We therefore used an extensively characterized chemLTP protocol in which neurons were treated with the NMDAR co-agonist glycine (200 μ[m]{.smallcaps}, 3 min, 37 °C) ([@B25], [@B26]). This procedure selectively activates only synaptic NMDARs. Strychnine was included in these experiments to block any possible direct effects on glycine receptors. As expected, surface expression of GluA2, was significantly increased using this chemLTP procedure ([Fig. 2](#F2){ref-type="fig"}, *A* and *C*) ([@B25]). In direct contrast to the reduction of GABA~B~Rs following bath application of NMDA, chemLTP increased surface expression of both GABA~B1~ and GABA~B2~ ([Fig. 2](#F2){ref-type="fig"}*A*). This increase was both rapid and sustained with 38.3% ± 28 and 24.6% ± 5.9 more GABA~B1~ and GABA~B2~, respectively, at 5 min and 75.4% ± 17.2 and 55.7% ± 4.3 at 20 min after stimulation ([Fig. 2](#F2){ref-type="fig"}*B*). The similar profiles for GABA~B1~ and GABA~B2~ suggest that, under these circumstances, the subunits are likely to be trafficked together as assembled GABA~B~Rs. The peak of AMPAR surface expression following chemLTP occurs between 15 to 20 min after the chemLTP stimulus ([@B25]). We therefore routinely monitored changes at 20 min, but we have also monitored experiments for 40 min with similar results.

![**Activation of synaptic NMDARs increases surface expression of GABA~B~Rs.** *A*, effects of glycine on GABA~B1~, GABA~B2~, and the AMPAR subunit GluA2 assessed by surface biotinylation. Cultured cortical neurons were treated with 200 μm glycine for 3 min and then incubated for 5 or 20 min without glycine before surface biotinylation and harvesting. Blots were probed with anti-GABA~B~ and anti-GluA2 antibodies and reprobed with anti-β-actin antibody to ensure equal loading and the specificity of surface biotinylation. *B*, quantification of the effect of chemLTP on GABA~B1~ and GABA~B2~. *C*, validation of chemLTP showing increased GluA2 protein surface expression. The results shown are the ratios of at least three independent experiments (*n* = 3). \*\*, *p* ≤ 0.01 and \*\*\*, *p* ≤ 0.005 compared with control (Student\'s *t* test). *D*, GABA~B~R endocytosis and recycling was measured by the loss of internalized GABA~B~R specifically labeled with cleavable (S = S linked) biotin. Cortical cultures were surface-biotinylated as described above, and cells were activated by chemLTP protocol and incubated for 5 or 20 min to allow internalized receptors to recycle before cleavage of surface biotin. Residual biotinylated (internal) receptors were then isolated from cells by streptavidin pulldown, and GABA~B~R subunits were detected by Western blotting. Blots were probed with anti- GABA~B1~ and anti-GABA~B2~ antibodies and reprobed with anti-β-actin antibody to ensure equal loading and the specificity of biotinylation. *E*, quantification of the effect of chemLTP on GABA~B1~ and GABA~B2~ rate of disappearance of biotinylated GABA~B~Rs provides a measure of receptor recycling. Leupeptin was included throughout the treatments to block any protein degradation or loss of internalized receptors. The results shown are the ratios of at least three independent experiments (*n* = 3). \*\*, *p* ≤ 0.01 and \*\*\*, *p* ≤ 0.005 compared with control (Student\'s *t* test). § (*p* ≤ 0.005), significant differences between with and without AP5 treatments.](zbc0131477440002){#F2}

We also used membrane-impermeant cleavable biotin to label surface-expressed GABA~B~ subunits. After labeling, neurons were incubated at 37 °C to allow constitutive internalization. The neurons containing internalized biotin-labeled GABA~B~ subunits were then subjected to chemLTP, and the surface biotin cleaved at the end of stimulation paradigm. In agreement with the imaging data, the amounts of biotinylated GABA~B~ subunits were decreased after chemLTP, suggesting either a decreased endocytosis or enhanced GABA~B~R recycling ([Fig. 2](#F2){ref-type="fig"}, *D* and *E*). Consistent with a previous report under basal conditions, 15.2% ± 1.5 GABA~B1~ and 16.3% ± 1.46 GABA~B2~ were present inside the cell (internal fraction) ([@B35]). Induction of chemLTP decreased the internal fraction of GABA~B1~ to 4.6% ± 1.6 and GABA~B2~ to 6.6% ± 2.6 after 20 min. This effect was blocked by application of the NMDAR antagonist AP5 during chemLTP protocol ([Fig. 2](#F2){ref-type="fig"}, *D* and *E*). Leupeptin was included in all the buffers to prevent degradation during the experiment.

#### ChemLTP Increases GABA~B~R Recycling

Recycling endosomes supply the AMPARs required for LTP ([@B26]). We therefore tested whether a similar recycling mechanism underlies the increase in surface GABA~B~R after chemLTP. We compared GABA~B~R to transferrin receptors (TfRs), which are constitutively internalized into early endosomes and then sorted to recycling endosomes ([Fig. 3](#F3){ref-type="fig"}*A*). As reported previously ([@B36]), after a 30-min incubation with Alexa Fluor 488-conjugated transferrin (Tf)-labeled TfR localized in intracellular endosomes. Under basal conditions, the Pearson\'s coefficients for co-localization of GABA~B1~ and GABA~B2~ with Tf were 0.52 ± 0.04 and 0.50 ± 0.01, respectively, suggesting constitutive recycling occurs for both subunits. Co-localization with Tf was significantly increased after chemLTP with the Pearson\'s coefficients of 0.69 ± 0.03 for GABA~B1~ and 0.59 ± 0.03 for GABA~B2~, indicating enhanced GABA~B~R recycling ([Fig. 3](#F3){ref-type="fig"}*B*). We used surface staining of the AMPAR subunit GluA1 colocalized with the postsynaptic marker PSD95 as a control for chemLTP protocol in hippocampal neurons. As expected, there was increase in colocalization of GluA1 with PSD95 in neurons subjected to chemLTP (Pearson\'s coefficients of 0.47 ± 0.02 in controls increasing to 0.62 ± 0.02 in chemLTP), confirming increased AMPAR surface expression and validating the chemLTP protocol ([Fig. 3](#F3){ref-type="fig"}, *C* and *D*).

![**ChemLTP increases GABA~B~R recycling.** *A*, representative images showing co-localization of GABA~B1~ and GABA~B2~ with the recycling marker Alexa Fluor 488-conjugated transferrin (*Alexa 488-Tf*). Hippocampal neurons were treated with 200 μ[m]{.smallcaps} glycine for 3 min and incubated at 37 °C for 20 min after replacing the buffer. *B*, quantification of the Pearson\'s coefficient for the co-localization of GABA~B1~ and GABA~B2~ with Alexa Fluor 488-Tf under basal conditions and 20 min after LTP induction as described in *A*. \*\*, *p* ≤ 0.01 (*n* = 12--16 cells). *C*, immunochemistry showing the co-localization of surface GluA1 (labeled under non-permeabilized conditions) and PSD95 in control and cells treated with glycine-mediated chemLTP as in *A. D*, histograms showing Pearsońs coefficient for the colocalization of GluA1 and PSD95 under basal conditions and after LTP induction as described in *C*. \*\*\*, *p* ≤ 0.001 (*n* = 32--33 cells). *E*, WT and dominant-negative (*DN*) Rab4 proteins fused to RFP were expressed in neurons using Sindbis virus and co-localized with GABA~B1~, GABA~B2~, and Alexa Fluor 488-Tf. *F*, Pearson\'s coefficients for the co-localization of GABA~B~Rs with Alexa Fluor 488-Tf in Rab4-WT and Rab4-DN-transduced cells after LTP induction as *E* (*n* = 19--33 cells). *Arrows* indicate colocalization.](zbc0131477440003){#F3}

Rab4 is involved in the rapid receptor recycling ([@B37]) and co-localizes with GABA~B~Rs ([@B38]). We therefore tested the affects of overexpressing dominant negative Rab4-DN on co-localization of GABA~B1~ and GABA~B2~ with Tf ([Fig. 3](#F3){ref-type="fig"}*E*). In neurons expressing wild type Rab4-WT the increase in the co-localization with Tf after chemLTP was comparable with non-infected control neurons for GABA~B1~ (Pearson\'s coefficients of GABA~B1~-Tf = 0.67 ± 0.02; GABA~B2~-Tf = 0.65 ± 0.02; [Fig. 3](#F3){ref-type="fig"}*F*). However, in neurons expressing Rab4-DN, there was no increase in GABA~B1~ or GABA~B2~ co-localization with Tf after chemLTP (Pearson\'s coefficient GABA~B1~-Tf = 0.48 ± 0.02; GABA~B2~-Tf = 0.46 ± 0.02; [Fig. 3](#F3){ref-type="fig"}*F*). We have also validated the Rab4 WT and DN constructs in control conditions. Consistent with previously published results under non-stimulated conditions, no significant changes were observed with the constructs compared with uninfected cells. In neurons expressing Rab4-WT (Pearson\'s coefficients of GABA~B1~-Tf = 0.57 ± 0.03; GABA~B2~-Tf = 0.55 ± 0.03) and Rab4-DN (Pearson\'s coefficient GABA~B1~-Tf = 0.53 ± 0.04; GABA~B2~-Tf = 0.52 ± 0.04).

To further investigate the chemLTP-induced increase in surface GABA~B1~ and GABA~B2~, we used live-cell imaging in neurons expressing myc-GABA~B1~ or HA-GABA~B2~. However, consistent with the fact that GABA~B1~ is only weakly surface-expressed in the absence of GABA~B2~, analysis of Myc-GABA~B1~ was confounded by poor surface expression ([Fig. 1](#F1){ref-type="fig"}*B*). Nonetheless, clear increases were observed for HA-GABA~B2~ at 10 and 20 min after chemLTP, and these were prevented by the recycling inhibitor monensin ([Fig. 4](#F4){ref-type="fig"}, *A* and *B*) ([@B39]). Taken together, these data strongly support the proposal that NMDAR activation controls GABA~B~R surface expression via regulation of the recycling endosomal pathway.

![**Monensin prevents chemLTP-induced increases in GABA~B~R surface expression.** *A*, hippocampal neurons were transfected with HA-GABA~B2~ and subjected to the glycine chemLTP protocol in either the presence or absence of 1 μ[m]{.smallcaps} monensin (*Monen*) for the times indicated. Surface expressed GABA~B~Rs were visualized with HA antibody. *B*, quantification of surface expression of HA-GABA~B2~ containing receptors at 0, 10, and 20 min after LTP induction as described in *A*. \*\*, *p* ≤ 0.01 (*n* = 4--5 cells per condition).](zbc0131477440004){#F4}

#### OGD Differentially Affects Surface Expression of GABA~B~R Subunits

Our results demonstrate that bath application of NMDA causes GABA~B~R internalization, whereas chemLTP evoked by activation of synaptic NMDARs increases surface GABA~B~R expression. Therefore, we next investigated how excitotoxic activation of NMDARs during OGD affects GABA~B~R surface expression. We have shown previously that 24 h after exposure of rat organotypic hippocampal slice cultures to OGD (45 min), there is a marked decrease in the total levels of GABA~B2~ (∼75%) but no significant change in the levels of GABA~B1~ ([@B19]). However, due to technical considerations, the slice culture experiments did not assess levels of GABA~B~R surface expression. Here, we have assessed the effects of 30, 45, and 60 min OGD on surface expression and total levels of GABA~B~R subunits in dispersed cultured neurons ([Fig. 5](#F5){ref-type="fig"}*A*). Consistent with our slice data, in this dispersed cell culture system total levels of GABA~B2~ were decreased (29.1% ± 15) and total levels of GABA~B1~ were unchanged ([Fig. 5](#F5){ref-type="fig"}, *A* and *D*). Interestingly, however, OGD significantly increased surface levels of GABA~B1~ (59.2% ± 18.9), whereas GABA~B2~ surface expression was decreased by 42.3% ± 12.5 ([Fig. 5](#F5){ref-type="fig"}, *A--C*). The NMDAR antagonist AP5 blocked these changes in GABA~B1~ and GABA~B2~ surface expression to differing extents. Thus, OGD regulates the surface trafficking of GABA~B~R subunits in opposite directions.

![**OGD increases GABA~B1~ and decreases GABA~B2~ surface expression.** *A*, cultured cortical neurons were exposed to OGD for the times indicated, and total and cell surface GABA~B1~ and GABA~B2~ were determined as described under "Experimental Procedures." Because there were OGD-induced changes in both total and surface expression of receptors, the fractions are normalized to actin levels individually, and the normalized percentages for surface (*B* and *C*) and total (*D*) are plotted separately. Blots were probed with anti-GABA~B~ antibodies and reprobed with anti-β-actin antibody to ensure equal loading and the specificity of surface biotinylation. *B* and *C*, quantification of surface GABA~B1~ and GABA~B2~, respectively, measured by biotinylation assays as illustrated in *A* (surface to actin ratio). *D*, total protein levels of GABA~B1~ and GABA~B2~ (total to actin). The results shown are the ratios of three independent experiments (*n* = 3). \*, *p* ≤ 0.05 and \*\*, *p* ≤ 0.01 compared with control (*Ctrl*; Students\'s *t* test). The *dashed line* represents control levels − 100%.](zbc0131477440005){#F5}

Protein degradation plays a pivotal role in receptor stability, trafficking, and recycling ([@B40]). The lysosomal inhibitor chloroquine and the proteasomal inhibitor MG132 increase total levels of GABA~B1~ and GABA~B2~ under both control and OGD conditions ([Fig. 6](#F6){ref-type="fig"}, *A* and *D*). Furthermore, OGD-induced GABA~B1~ surface expression was enhanced by either chloroquine or MG132, indicating that both proteasomal and lysosomal pathways can degrade GABA~B1~ ([Fig. 6](#F6){ref-type="fig"}, *A* and *B*). Intriguingly, chloroquine or MG132 also prevented the OGD-induced decrease in surface GABA~B2~ ([Fig. 6](#F6){ref-type="fig"}, *A* and *C*). In contrast, inclusion of the recycling inhibitor monensin during OGD caused a marked decrease in total levels and surface expression levels of GABA~B~Rs ([Fig. 6](#F6){ref-type="fig"}, *A--D*). We attribute this to blockade of recycling leading to the sorting of constitutively endocytosed receptors to degradation pathways during OGD ([@B11]). We also observed that in control conditions there was decrease in surface and total levels of GABA~B~Rs following monensin treatment. This observation is consistent with previously published data suggesting that block in recycling traffics the receptors to lysosomes ([@B35]). Similar to our chemLTP experiments where monensin prevented the increase in GABA~B~ receptors, the fact that monensin blocked the OGD-induced increase in surface GABA~B1~ suggests that enhanced recycling is a core mechanism underlying these effects.

![**GABA~B~R trafficking in OGD.** Effects of OGD on GABA~B1~ and GABA~B2~ surface expression assessed by surface biotinylation. *A*, cultured cortical neurons were incubated with 50 μ[m]{.smallcaps} AP5 (NMDAR antagonist), 10 μ[m]{.smallcaps} MG132 (proteasome inhibitor), 10 μ[m]{.smallcaps} chloroquine (*ChloQ*, lysosomal inhibitor) or 1 μ[m]{.smallcaps} monensin (*Monen*, recycling blocker). Blots were probed with anti-GABA~B~ antibodies and reprobed with anti-β-actin antibody to ensure equal loading and the specificity of surface biotinylation. *B* and *C*, quantification of surface expression for GABA~B1~ and GABA~B2~, respectively (surface to actin ratio). *D*, total protein levels for GABA~B1~ and GABA~B2~. The data are the ratios of three independent experiments (*n* = 3). \*, *p* ≤ 0.05; \*\*, *p* ≤ 0.01; \*\*\*, *p* ≤ 0.005, compared with OGD-treated neurons (Students\'s *t* test). The *dashed line* is control levels − 100%.](zbc0131477440006){#F6}

#### GABA~B1~ and GABA~B2~ Recycling Are Separately Regulated during OGD

To investigate the recycling properties of GABA~B~R subunits following OGD, we performed functional co-localization analysis with the TfR. As shown in [Fig. 3](#F3){ref-type="fig"}, under basal conditions, the Pearson\'s coefficients of GABA~B1~ and GABA~B2~ co-localization with TfR were 0.52 ± 0.03 and 0.51 ± 0.02, respectively, consistent with both subunits undergoing constitutive recycling. After 30 min of OGD, however, Pearson\'s coefficients for co-localization with TfR were 0.65 ± 0.01 and 0.35 ± 0.07 for GABA~B1~ and GABA~B2~, respectively ([Fig. 7](#F7){ref-type="fig"}, *A* and *B*). We next tested the effects of expressing Rab4-WT or Rab4-DN ([Fig. 7](#F7){ref-type="fig"}*C*). In Rab4-WT expressing neurons, the increase in the co-localization with Tf after OGD was similar to non-infected cells for GABA~B1~ ([Fig. 7](#F7){ref-type="fig"}, *A* and *B*). For GABA~B2~, however, the levels were comparable to control (Pearson\'s coefficient GABA~B1~-Tf = 0.63 ± 0.02; GABA~B2~-Tf = 0.51 ± 0.03) ([Fig. 7](#F7){ref-type="fig"}, *C* and *D*). This suggests that Rab4-WT overcomes the OGD-induced reduction on GABA~B2~ recycling. Expression of Rab4-DN blocked OGD-induced changes in GABA~B~R subunit co-localization with Tf (Pearson\'s coefficient GABA~B1~-Tf = 0.51 ± 0.03; GABA~B2~-Tf = 0.40 ± 0.03) ([Fig. 7](#F7){ref-type="fig"}*D*). Interestingly, expressing Rab4-DN did not alter OGD-induced changes in GABA~B2~, suggesting that there is no further decrease in recycling rates during OGD when Rab4-DN is expressed. Consistent with our biochemistry data, these results demonstrate differential trafficking of the individual subunits and indicate that the increase in GABA~B1~ surface expression is due to increased recycling and that the decrease in GABA~B2~ surface expression is due to reduced recycling and/or increased sorting to degradative pathways.

![**OGD regulates GABA~B~R expression by modulating recycling.** *A*, co-localization of GABA~B1~ and GABA~B2~ with Alexa Fluor 488-Tf in control (*Ctrl*) and OGD-treated cultured hippocampal neurons. *B*, Pearson\'s coefficients for the co-localization of GABA~B1~ and GABA~B2~ with Alexa Fluor 488-Tf. The data are representative of at least three separate experiments (*n* = 22 cells per condition). \*\*, *p* ≤ 0.01. *C*, co-localization of GABA~B1~ and GABA~B2~ with Alexa Fluor 488-Tf in control and OGD-treated cultured hippocampal neurons expressing Rab4-WT or Rab4-DN. *D*, Pearson\'s coefficients for the co-localization of GABA~B1~ and GABA~B2~ with Alexa Fluor 488-Tf. The data are the ratios of independent experiments (*n* = 2, 20--21 cells per condition). \*\*, *p* ≤ 0.01; \*\*\*, *p* ≤ 0.005, compared with OGD-treated neurons (Students\'s *t* test). *Arrows* indicate colocalization.](zbc0131477440007){#F7}

DISCUSSION
==========

We show that activation of synaptic NMDARs increases GABA~B~R surface expression by enhancing recycling of both GABA~B1~ and GABA~B2~ ([Fig. 8](#F8){ref-type="fig"}). We used well established and routinely used glycine-induced chemLTP ([@B25], [@B26], [@B41], [@B42]). The co-agonist glycine ([@B43]) acts synergistically with spontaneously released glutamate in the synaptic cleft to activate synaptic NMDARs and induce LTP. To exclude any potential confounding effect from activation of inhibitory glycine receptors, we included the glycine receptor antagonist strychnine in the LTP buffer.

![**Schematic of chem-LTD, chemLTP, and OGD-mediated GABA~B~R trafficking.** *A*, under basal state, GABA~B~Rs are cycled constitutively at plasma membrane. *B*, after LTD, endocytosed GABA~B1~ and GABA~B2~ are sorted to lysosomes ([@B21], [@B22]). *C*, after chemLTP, endocytosed GABA~B1~ and GABA~B2~ are sorted to recycling endosomes and returned to the plasma membrane increasing surface expression of both GABA~B~ subunits. *D*, OGD leads to differential trafficking of GABA~B~Rs. There is enhanced recycling of GABA~B1~ to plasma membrane, whereas GABA~B2~ is degraded via proteasomal and/or lysosomal pathways. *MVB*, multivesicular bodies; *ER*, endoplamic reticulum.](zbc0131477440008){#F8}

Our results show that, like excitatory AMPARs, inhibitory GABA~B~Rs undergo a form of NMDAR-dependent plasticity. Furthermore, these data are consistent with the observation that NMDAR-invoked AMPAR mediated LTP in postsynaptic CA1 pyramidal neurons also causes LTP of the slow inhibitory postsynaptic current-mediated by GABA~B~Rs ([@B44]).

GABA released from interneurons can activate both pre- and postsynaptic GABA~B~Rs at glutamatergic synapses ([@B45]). Enhanced presynaptic GABA~B~R surface expression reduces glutamate release and elicits hyperpolarizing inhibitory postsynaptic potentials that facilitate the Mg^2+^ block of NMDARs and reduce Ca^2+^ signaling ([@B17], [@B18], [@B20]). Thus, the likely role of the chemLTP-induced increase GABA~B~Rs at glutamatergic synapses is to enhance inhibitory tone to counterbalance the increase in AMPARs and prevent hyperexcitability. These data highlight the complex inter-relationship and cross-talk between inhibitory and excitatory receptors that varies depending on the profile of NMDAR activation.

Under basal conditions, both GABA~B1~ and GABA~B2~ co-localize with TfR-positive recycling endosomal compartments indicating that GABA~B~Rs undergo constitutive recycling. Furthermore, this co-localization increases following chemLTP and the chemLTP-induced increase in GABA~B1~ and GABA~B2~ surface expression is prevented by blocking recycling with monensin or Rab4-DN. These results suggest that selective activation of synaptic NMDARs enhances sorting to recycling pathways and away from degradation. Moreover, they extend previous observations that heterodimeric GABA~B~Rs undergo clathrin- and dynamin-1-dependent endocytosis and recycle back to the cell surface ([@B21]). As this is routine practice in the glutamate and GABA receptor fields, we used hippocampal neurons for immunocytochemistry and cortical neurons for biochemistry. Importantly, in this study, and the many previous studies, the biochemical data from cortical neurons is entirely consistent with the imaging data from hippocampal neurons.

Consistent with previous observations ([@B10], [@B21][@B22][@B23]), we found that NMDA (5 min, 50 μ[m]{.smallcaps}) decreased surface expression of both GABA~B1~ and GABA~B2~. Activation of extrasynaptic NMDARs is neurotoxic and can serve as a potent signal for cell death ([@B24]). We therefore reasoned that similar effects on GABA~B~R trafficking might occur following excitotoxic events similar to epilepsy or in severe oxidative stress such as ischemia where there is prolonged and diffuse glutamate release.

Our previous work demonstrated that OGD causes a 70% reduction in total levels of GABA~B2~ but has no effect on total levels of GABA~B1~ ([@B19]). Here, we confirm that total levels of GABA~B2~ are decreased and GABA~B1~ totals are unchanged. Additionally, we show that pathological activation of NMDARs during OGD results in a 50% increase in surface-expressed GABA~B1~ and a 40% decrease in surface GABA~B2~, presumably altering the composition of surface GABA~B~Rs ([Fig. 8](#F8){ref-type="fig"}). OGD is a form of severe metabolic oxidative stress that has multiple effects in cells, including raised free radical production, ATP depletion, increased levels of intracellular Ca^2+^, and the release of high amounts of glutamate. Under these stressed conditions, the individual GABA~B~R subunits appear to undergo independent endocytosis, recycling, and degradation. These results highlight the fact that exogenous agonist addition does not necessarily have the same effects as physiological or pathophysiological stimulation.

Taken together, we interpret our data to suggest that surface expressed GABA~B~R complexes are dynamic and may disassemble while in the membrane. Interestingly, chronic stimulation with capsaicin can cause GABA~B~R heterodimers to dissociate with the individual subunits subject to differential trafficking ([@B12]). Indeed, a high proportion of GABA~B~R subunits are monomers segregated in distinct dendritic compartments, whereas assembled GABA~B~R heteromers are preferentially located at the plasma membrane ([@B46]). How the differential regulation of GABA~B~R subunits is achieved, and the consequent cellular effects, are important outstanding questions.

We attribute the increase in surface GABA~B1~ following OGD to the recycling of a higher proportion of this subunit to the membrane because the effect was blocked by monensin. In addition, OGD directly promotes GABA~B2~ degradation following internalisation and the OGD-induced decrease in surface GABA~B2~ was completely blocked by proteasome or lysosome inhibition. Because functional GABA~B~Rs have to be heterodimers, the decrease in surface GABA~B2~ causes a substantial decrease in GABA~B~R signaling following OGD. Further work is needed, but we hypothesize that this loss of inhibition could provide a mechanism to drive damaged cells toward death via excitoxicity. In addition, the increase in GABA~B1~ subunit surface expression might act to chelate GABA or heterodimerise with other G protein-coupled receptors ([@B47]) to produce differential signaling.

In conclusion, our findings indicate that the fates of surface expressed GABA~B~R subunits are separately regulated under chemLTP and OGD conditions and that individual subunits recycle independently. Based on these data, we propose that the surface expression or endocytosis of GABA~B~Rs arising from different modes of NMDAR activation represents an important mechanism that regulates neuronal responsiveness and survival.
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